AzTrials
AzTrials

Diaphragm Electrical ActivityNCT07020299

Effect of Electrical Diaphragmatic Stimulation on Chronic Obstructive Pulmonary Disease

A study testing Device : Digital electrical muscle stimulator is applied to induce diaphragm contraction. in people with Diaphragm Electrical Activity and COPD (Chronic Obstructive Pulmonary Disease), run by Mansoura University Hospital at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Respiratory muscle dysfunction is a common consequence of chronic obstructive pulmonary disease (COPD). This technique consists of placing electrodes on the skin at locations near the motor points of the diaphragm, transmitting an intermittent current, and generating action potentials capable of producing muscle… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Device : Digital electrical muscle stimulator is applied to induce diaphragm contraction.
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteEgypt
Study dates
1 Aug 2024to 1 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age >18 years.
  • Known cases of COPD admitted at respiratory critical care unit with severe acute exacerbation (defined according to GOLD 2024).

Who cannot join

  • Body mass index (BMI) > 35 kg/m2
  • Post arrest patients
  • Brain death
  • Hemodynamic instability
  • Invasive MV
  • Lung disease other than COPD
Show all 13Show fewer
  • Pregnancy , ascitis.
  • History of neuromuscular disease at admission
  • Spinal injuries
  • Skin lesions or an open lesion in the regions where the electrodes would be placed
  • Use of pacemakers
  • Patients on maintenance steroid therapy
  • Depletating disease as malignancy 14. Patients refusing the procedure

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of medicine mansoura university

    Al Mansurah, 35516

Other trials in Egypt

About this study

Official title: Effect of Trans-cutenuous Electrical Diaphragmatic Stimulation on Severe Chronic Obstructive Pulmonary Disease Exacerbation

Respiratory muscle dysfunction is a common consequence of chronic obstructive pulmonary disease (COPD).

This technique consists of placing electrodes on the skin at locations near the motor points of the diaphragm, transmitting an intermittent current, and generating action potentials capable of producing muscle contractions

Read the detailed description

Respiratory muscle dysfunction is a common consequence of chronic obstructive pulmonary disease (COPD).Weakness or fatigue of the diaphragm and accessory muscles of inspiration is widely recognized in patients on mechanical ventilation. There is increasing evidence to show mechanical ventilation itself may adversely affect the diaphragm's structure and function, which has been termed ventilator-induced diaphragmatic dysfunction. However, in patients with more severe COPD, the benefits of rehabilitation may be limited. In this context, there are new approaches to PR, such as electrical stimulation, a technique that externally stimulates contractions of peripheral muscles to improve peripheral muscle function in patients with severe COPD. This technique consists of placing electrodes on the skin at locations near the motor points of the diaphragm, transmitting an intermittent current, and generating action potentials capable of producing muscle contractions

Being tested
Device : Digital electrical muscle stimulator is applied to induce diaphragm contraction.
Keywords
chronic obstructive pulmonary disease exacerbation, Electrical diaphragmatic stimulation
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Device : Digital electrical muscle stimulator is applied to induce diaphragm contraction.Device

    TEDS group will be subjected to sessions of TEDS as follow : Digital electrical muscle stimulator (EV-906 Digital TENS/EMS made in TAIWAN) is applied to induce diaphragm contraction.

Study groups in NCT07020299
Study groupRoleWhat they receive
TEDS group will be subjected to sessions of TEDSActive comparatorTEDS group will be subjected to sessions of TEDS as follow : Digital electrical muscle stimulator (EV-906 Digital TENS/EMS made in TAIWAN) is applied to induce diaphragm contraction.
Receives: Device: Device : Digital electrical muscle stimulator is applied to induce diaphragm contraction.
Non TEDS group will not be subjected to sessions of TEDSNo interventionNon TEDS group will not be subjected to sessions of TEDS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome is the progression to invasive mechanical ventilation(IMV)

    Functional assessment by US measurement of diaphragmatic excursion and thickness fraction in (cm) including base line measurement and post treatment measurement ( at the end of admission).

    Measured: 6 months

Secondary outcomes (1)
  1. The secondary outcomes is the duration of ICU admission

    The secondary outcomes is the duration of ICU admission (days), the immediate effect of TEDS and after sessions.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2025
  2. Study start1 Aug 2024
  3. Primary completion1 Feb 2025
  4. Study completion1 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Effect of trans-cutenuous electrical diaphragmatic stimulation on severe chronic obstructive pulmonary disease exacerbation
Masking
Single blind
Who is masked
Care provider
Enrolment
128 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07020299
Sponsor's protocol ID
MD.24.08.878
Status last verified
Aug 2026
First submitted
27 May 2025
Last updated
18 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Device : Digital electrical muscle stimulator is applied to induce diaphragm contraction. in people with Diaphragm Electrical Activity and COPD (Chronic Obstructive Pulmonary Disease), run by Mansoura University Hospital at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome is the progression to invasive mechanical ventilation(IMV) (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in